HOME >> BIOLOGY >> NEWS
Full-year results from Oxford Open show wide variation in open access uptake across disciplines

Oxford Journals, a division of Oxford University Press, today released full year figures from its optional open access experiment, Oxford Open (http://www.oxfordjournals.org/oxfordopen/). In the first year of launch, almost 400 papers have been published under the optional open access model across 36 of the 49 participating titles.

The majority of uptake of optional open access has, as predicted, been in the life sciences, with approximately 10% of authors selecting the open access option across 16 participating journals in this area, compared with approximately 5% in medicine and public health, and 3% in the humanities and social sciences. Three life sciences titles in the areas of molecular and computational biology have seen over 20% uptake. The highest of these was for Bioinformatics, which has published over 50 open access papers in 2006. 2007 online subscription prices have been adjusted for these journals to reflect this uptake.

Oxford Open, launched in July 2005, gives authors the option of paying for their research to be made freely available online immediately upon publication in the participating journals. Twenty-one titles adopted this model in July 2005, and further titles have joined in 2006, giving 49 journals participating at present.

Claire Bird, Senior Editor, Oxford Journals, commented, "we continue to see wide variation in uptake, and different levels of interest in 'author-pays' open access models between disciplines. The highest uptake has been in areas where more funding for open access is available, such as the life sciences, and we would expect this trend to continue in 2007."

Managing Director, Martin Richardson also commented: "We launched Oxford Open to help foster a better understanding of the advantages and disadvantages of open access and subscription-based business models. These results show that while open access is beginning to be
'"/>

Contact: Mithu Mukherjee
mithu.mukherjee@oxfordjournals.org
01-865-354-471
Oxford University Press
30-Aug-2006


Page: 1 2

Related biology news :

1. Cooperative science program yields results
2. Delayed treatment of childhood-onset bipolar disorder results in negative outcome in adults
3. Smelling for first time results from knowing abnormalities in congenital loss of smell
4. BDSI announces positive phase III clinical trial results
5. Scientists meet to review Envisat results after 5 years of operations
6. Environment and exercise may affect research results, UA study shows
7. Preliminary results of largest scan of autism DNA information
8. Human trial results show excellent safety data, from Geovaxs DNA/MVA AIDS vaccines
9. Rodent sperm work together for better results
10. Dramatic results from combo therapy surprises Krabb-disease researchers
11. TIGER workshop highlights project results

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: